Tag Archives: Bill & Melinda Gates Foundation

US Cuts Could Jeopardize Global Health Innovations, Says Report

By Julian Upton | Published: February 20, 2013
Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report by the Global Health Technologies Coalition.
Posted in Events | Also tagged , , , , | Leave a comment

Challenges in the March Toward an AIDS-Free Generation

By Ben Comer | Published: August 1, 2012
FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.
Posted in Biotech, Events, FDA, Market Access, Patient Communication, Regulatory, Safety, healthcare, patient compliance, patient education, pricing | Also tagged , , , , , , | Leave a comment

A Critical Path to New TB Treatments

By George Koroneos | Published: March 18, 2010
Image via Wikipedia FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, providing [...]
Posted in R&D | Also tagged , , , , , , | 2 Comments